RIGEL PHARMACEUTICALS INC (RIGL)       1.15  -0.01 (-0.86%)

1.15  -0.01 (-0.86%)

US7665596034 - Common Stock - After market: 1.15 0 (0%)

MRQ
(2022-6-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
ASSETS
Current Assets
Cash Equivalents
27.20M18.89M30.40M22.50M76.30M
Marketable Securities
61.97M106.08M27.00M75.60M52.20M
Receivables
17.20M15.47M16.00M10.10M4.10M
Inventories
6.22M6.62M1.60M1.40M900.00K
Other Current Assets
7.94M7.41M14.00M9.50M3.50M
Total Current Assets
120.52M154.47M89.00M119.00M137.00M
 
Non-Current Assets
PPE Net
7.08M11.89M20.60M27.90M1.40M
Other Non-Current Assets
403.00K974.00K800.00K700.00K700.00K
Total Non-Current Assets
7.48M12.86M21.40M28.60M2.10M
 
TOTAL ASSETS
128.00M167.33M110.40M147.60M139.10M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Accounts Payable And Accrued Liabilities
2.15M3.79M3.70M4.20M6.40M
Accrued Expenses
39.43M43.66M34.10M28.80M20.30M
Other Current Liabilities
13.37M16.10M3.00M25.30M1.00M
Total Current Liabilities
54.95M63.55M40.80M58.20M27.70M
 
Non-Current Liabilities
Long Term Debt
29.84M19.91M19.80M9.80M0.00
Other Non-Current Liabilities
46.89M53.49M15.70M25.70M1.50M
Total Non-Current Liabilities
76.72M73.40M35.60M35.60M1.50M
 
TOTAL LIABILITIES
131.68M136.95M76.40M93.80M29.20M
 
SHAREHOLDERS' EQUITY
Additional Paid In Capital
1.36B1.35B1.34B1.33B1.32B
Shares Outstanding
172.84M171.60M169.30M168.00M167.20M
Common Shares
173.00K172.00K200.00K200.00K200.00K
Retained Earnings
-1.36B-1.32B-1.31B-1.28B-1.21B
Other Shareholders' Equity
-438.00K-102.00K0.000.000.00
Total Shareholders' Equity
-3.68M30.37M34.00M53.80M109.90M
 
TOTAL LIABILITIES AND EQUITY
128.00M167.33M110.40M147.60M139.10M
 
Statistics
Debt/Equity
-8.110.660.580.18N/A
Current Ratio
2.192.432.182.044.95
Return On Assets (ROA)
-66.04%-10.71%-26.90%-45.33%-50.68%
Return On Equity (ROE)
N/A-58.98%-87.35%-124.35%-64.15%

All data in USD

Charts